Myrbetriq

Common use

Myrbetriq is used in adults to treat overactive bladder with symptoms of frequent or urgent urination and urinary incontinence. It is sometimes used together with another medicine called solifenacin. Myrbetriq is used in children to treat neurogenic detrusor overactivity (NDO). Urinary incontinence caused by NDO is related to permanent nerve damage from conditions such as multiple sclerosis or spinal injury.

Dosage and direction

Take the Myrbetriq tablet with a full glass of water. Swallow the tablet whole and do not crush, chew, or break it. An adult may take a Myrbetriq tablet with or without food. However, a child should take the tablet with food.

Precautions

To make sure this medicine is safe for you, tell your doctor if you have: high blood pressure; a bladder obstruction; trouble emptying your bladder (very little urine or a weak stream of urine); kidney disease; or liver disease.
Tell your doctor if you are pregnant or breastfeeding.

Contraindications

You should not use Myrbetriq if you are allergic to mirabegron.
You should not use Myrbetriq if you have: end stage renal disease (kidney failure); severe kidney disease; or severe uncontrolled high blood pressure.

Possible side effect

Common Myrbetriq side effects may include: painful urination; increased blood pressure; sinus pain, sore throat; constipation; headache; or dry mouth or fast heartbeats (when taken with solifenacin).

Drug interaction

Tell your doctor about all your other medicines, especially: digoxin; flecainide; propafenone; solifenacin; or thioridazine.

Missed dose

Use the medicine as soon as you can, but skip the missed dose if you are more than 12 hours late for the dose. Do not use two doses at one time.

Overdose

Seek emergency medical attention. An overdose may cause pounding heartbeats or fluttering in your chest.

Storage

Store at room temperature away from moisture and heat. Keep away from children and pets.